Subtyping prostate cancer to predict response to hormone therapy Grant US-11873532-B2 United States of America 16 Jan 2024
Use of genomic signatures to predict responsiveness of patients with prostate cancer to… Grant US-11414708-B2 United States of America 16 Aug 2022
Molecular subtyping, prognosis, and treatment of bladder cancer Grant US-11208697-B2 United States of America 28 Dec 2021
Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness Grant US-11078542-B2 United States of America 03 Aug 2021
ANTISENSE OLIGONUCLEOTIDE SEQUENCES FOR SILENCING THE HUMAN L1-MET TRANSCRIPT IN TUMOURS Application WO-2021095080-A1 World Intellectual Property Organisation (WIPO) 20 May 2021
Sequenze di oligonucleotidi antisenso per silenziare il trascritto L1-MET umano nei tumori. N/A IT-201900021327-A1 Italy 15 May 2021
Systems and methods for expression-based discrimination of distinct clinical disease… Grant US-10865452-B2 United States of America 15 Dec 2020
Cancer diagnostics using non-coding transcripts Grant US-10513737-B2 United States of America 24 Dec 2019
Biomarker panels for predicting prostate cancer outcomes Grant US-10407731-B2 United States of America 10 Sep 2019
Monoclonal antibody to human line-1 ORF2 protein and method for early detection of… Grant US-10214591-B1 United States of America 26 Feb 2019